115 related articles for article (PubMed ID: 25001144)
1. Re: Lovastatin for reduction of leptin in nondialysis patients with type 2 diabetic nephropathy.
Ahmadi F; Mohebi-Nejad A
Iran J Kidney Dis; 2014 Jul; 8(4):344-5. PubMed ID: 25001144
[No Abstract] [Full Text] [Related]
2. Lovastatin for reduction of leptin in nondialysis patients with type 2 diabetic nephropathy.
Gholamin S; Razavi SM; Taghavi-Garmestani SM; Ghorbanihaghjo A; Rashtchizadeh N; Safa J; Vatankhah AM; Azizi T; Argani H
Iran J Kidney Dis; 2014 May; 8(3):201-6. PubMed ID: 24878942
[TBL] [Abstract][Full Text] [Related]
3. Lovastatin raises serum osteoprotegerin level in people with type 2 diabetic nephropathy.
Nezami N; Safa J; Eftekhar-Sadat AT; Salari B; Ghorashi S; Sakhaee K; Khosraviani K
Clin Biochem; 2010 Nov; 43(16-17):1294-9. PubMed ID: 20727867
[TBL] [Abstract][Full Text] [Related]
4. C-reactive protein level following treatment and withdrawal of lovastatin in diabetic nephropathy.
Rashtchizadeh N; Argani H; Ghorbanihaghjo A; Nezami N; Safa J; Montazer-Saheb S
Iran J Kidney Dis; 2009 Apr; 3(2):93-8. PubMed ID: 19395785
[TBL] [Abstract][Full Text] [Related]
5. [Better prognosis for dialysis dependent type 2 diabetic patient. Statin delays arterial onset of arterial stiffness].
MMW Fortschr Med; 2003 Apr; 145(16):60. PubMed ID: 14606406
[No Abstract] [Full Text] [Related]
6. Effect of lovastatin therapy and withdrawal on serum uric acid level in people with type 2 diabetic nephropathy.
Nezami N; Safa J; Salari B; Ghorashi S; Khosraviani K; Davari-Farid S; Hashemi-Aghdam Y; Nargabad ON; Tabrizi JS
Nucleosides Nucleotides Nucleic Acids; 2012 Apr; 31(4):353-63. PubMed ID: 22444196
[TBL] [Abstract][Full Text] [Related]
7. Effect of HMG-CoA reductase inhibitors on reduction of panel reactivity.
Ossareh S; Ghorbani G; Ghods AJ
Transplant Proc; 2003 Nov; 35(7):2592-3. PubMed ID: 14612031
[No Abstract] [Full Text] [Related]
8. Who does not need a statin: too late in end-stage renal disease or heart failure?
Laufs U; Custodis F; Böhm M
Postgrad Med J; 2009 Apr; 85(1002):187-9. PubMed ID: 19417167
[TBL] [Abstract][Full Text] [Related]
9. [A short-term effect of lovastatin on lipoprotein metabolism in patients with cerebrovascular lesions concomitant with diabetes mellitus II type].
Bozhko GKh; Sokolik VV; Chursina VS; Pertseva TG
Zh Nevrol Psikhiatr Im S S Korsakova; 2006; Suppl 17():47-51. PubMed ID: 18193578
[TBL] [Abstract][Full Text] [Related]
10. Simvastatin reduces plasma osteoprotegerin in type 2 diabetic patients with microalbuminuria.
Nellemann B; Gormsen LC; Dollerup J; Schmitz O; Mogensen CE; Rasmussen LM; Nielsen S
Diabetes Care; 2007 Dec; 30(12):3122-4. PubMed ID: 17804683
[No Abstract] [Full Text] [Related]
11. [Nephrology].
Saudan P; Martin PY
Rev Med Suisse; 2012 Jan; 8(323):41-5. PubMed ID: 22303739
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of statins in patients with diabetic nephropathy: a meta-analysis of randomized controlled trials.
Shen X; Zhang Z; Zhang X; Zhao J; Zhou X; Xu Q; Shang H; Dong J; Liao L
Lipids Health Dis; 2016 Oct; 15(1):179. PubMed ID: 27733168
[TBL] [Abstract][Full Text] [Related]
13. [Diabetes and Nephropathy: ACE inhibitor for type 1, AT1 blocker for type 2].
Zidek W
MMW Fortschr Med; 2004 Oct; 146(42):51-2. PubMed ID: 15536706
[No Abstract] [Full Text] [Related]
14. Modulating effect of atorvastatin on paraoxonase 1 activity in type 2 diabetic Egyptian patients with or without nephropathy.
Abdin AA; Hassanien MA; Ibrahim EA; El-Noeman Sel-D
J Diabetes Complications; 2010; 24(5):325-33. PubMed ID: 19553142
[TBL] [Abstract][Full Text] [Related]
15. [Metformin is also recommended in mild and moderate renal failure].
Zechmann S
Praxis (Bern 1994); 2015 Mar; 104(7):370-1. PubMed ID: 25804780
[No Abstract] [Full Text] [Related]
16. [Hypothyroidism and lovastatin-induced myositis].
Rodríguez Framil M; Martínez Rey C; Alende Sixto MR; Torre Carballada JA
An Med Interna; 2005 May; 22(5):252-3. PubMed ID: 16089017
[No Abstract] [Full Text] [Related]
17. Twenty years after ACEIs and ARBs: emerging treatment strategies for diabetic nephropathy.
Johnson SA; Spurney RF
Am J Physiol Renal Physiol; 2015 Nov; 309(10):F807-20. PubMed ID: 26336162
[TBL] [Abstract][Full Text] [Related]
18. Comparison of a statin vs. hypolipemic diet on the oxidant status in hemodialyzed patients with chronic renal failure.
Mastalerz-Migas A; Reksa D; Pokorski M; Steciwko A; Muszyńska A; Bunio A; Drobnik J; Pokorna-Kałwak D
J Physiol Pharmacol; 2007 Nov; 58 Suppl 5(Pt 1):363-70. PubMed ID: 18204148
[TBL] [Abstract][Full Text] [Related]
19. [Diabetes treatment in patients with chronic kidney disease].
Süfke S; Steinhoff J; Schütt M
Dtsch Med Wochenschr; 2013 May; 138(21):1109-18; quiz 1119-22. PubMed ID: 23677506
[No Abstract] [Full Text] [Related]
20. Lovastatin effects on bone mineral density in postmenopausal women with type 2 diabetes mellitus.
Safaei H; Janghorbani M; Aminorroaya A; Amini M
Acta Diabetol; 2007 Jun; 44(2):76-82. PubMed ID: 17530471
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
